Hepatocellular carcinoma surveillance in a western population with hepatitis B

Jennifer Urquhart, Jonathan M. Schwartz

Research output: Contribution to journalArticle

Abstract

Hepatocellular carcinoma (HCC) is a malignant tumor arising primarily in cirrhotic livers as a consequence of chronic hepatitis B or C virus infection or alcohol-induced cirrhosis. Unlike the majority of other common cancer types, the incidence of HCC in the United States is still rising, with peak incidence expected for 2020. Although hepatitis B is a less common etiology for the development of HCC in the West, it is the most common risk factor among certain ethnic groups in the United States. Given the high case fatality of HCC, surveillance efforts have been recommended. Specifically, HCC surveillance has demonstrated a survival benefit in patients with chronic hepatitis B. In this review, we discuss the demographics of patients with HCC in the United States, the evidence promoting surveillance, and recent literature identifying the best surveillance test.

Original languageEnglish (US)
Pages (from-to)147-152
Number of pages6
JournalCurrent Hepatitis Reports
Volume10
Issue number2
DOIs
StatePublished - Jun 2011
Externally publishedYes

Fingerprint

Hepatitis B
Hepatocellular Carcinoma
Population
Chronic Hepatitis B
Incidence
Chronic Hepatitis C
Virus Diseases
Ethnic Groups
Hepatitis B virus
Hepacivirus
Neoplasms
Fibrosis
Alcohols
Demography
Survival
Liver

Keywords

  • Hepatitis B
  • Hepatocellular carcinoma
  • Serum α-fetoprotein
  • Surveillance
  • Ultrasound

ASJC Scopus subject areas

  • Hepatology
  • Virology

Cite this

Hepatocellular carcinoma surveillance in a western population with hepatitis B. / Urquhart, Jennifer; Schwartz, Jonathan M.

In: Current Hepatitis Reports, Vol. 10, No. 2, 06.2011, p. 147-152.

Research output: Contribution to journalArticle

@article{c897155452294595b92f1b39ac6080a6,
title = "Hepatocellular carcinoma surveillance in a western population with hepatitis B",
abstract = "Hepatocellular carcinoma (HCC) is a malignant tumor arising primarily in cirrhotic livers as a consequence of chronic hepatitis B or C virus infection or alcohol-induced cirrhosis. Unlike the majority of other common cancer types, the incidence of HCC in the United States is still rising, with peak incidence expected for 2020. Although hepatitis B is a less common etiology for the development of HCC in the West, it is the most common risk factor among certain ethnic groups in the United States. Given the high case fatality of HCC, surveillance efforts have been recommended. Specifically, HCC surveillance has demonstrated a survival benefit in patients with chronic hepatitis B. In this review, we discuss the demographics of patients with HCC in the United States, the evidence promoting surveillance, and recent literature identifying the best surveillance test.",
keywords = "Hepatitis B, Hepatocellular carcinoma, Serum α-fetoprotein, Surveillance, Ultrasound",
author = "Jennifer Urquhart and Schwartz, {Jonathan M.}",
year = "2011",
month = "6",
doi = "10.1007/s11901-011-0098-y",
language = "English (US)",
volume = "10",
pages = "147--152",
journal = "Current Hepatitis Reports",
issn = "1540-3416",
publisher = "Springer Publishing Company",
number = "2",

}

TY - JOUR

T1 - Hepatocellular carcinoma surveillance in a western population with hepatitis B

AU - Urquhart, Jennifer

AU - Schwartz, Jonathan M.

PY - 2011/6

Y1 - 2011/6

N2 - Hepatocellular carcinoma (HCC) is a malignant tumor arising primarily in cirrhotic livers as a consequence of chronic hepatitis B or C virus infection or alcohol-induced cirrhosis. Unlike the majority of other common cancer types, the incidence of HCC in the United States is still rising, with peak incidence expected for 2020. Although hepatitis B is a less common etiology for the development of HCC in the West, it is the most common risk factor among certain ethnic groups in the United States. Given the high case fatality of HCC, surveillance efforts have been recommended. Specifically, HCC surveillance has demonstrated a survival benefit in patients with chronic hepatitis B. In this review, we discuss the demographics of patients with HCC in the United States, the evidence promoting surveillance, and recent literature identifying the best surveillance test.

AB - Hepatocellular carcinoma (HCC) is a malignant tumor arising primarily in cirrhotic livers as a consequence of chronic hepatitis B or C virus infection or alcohol-induced cirrhosis. Unlike the majority of other common cancer types, the incidence of HCC in the United States is still rising, with peak incidence expected for 2020. Although hepatitis B is a less common etiology for the development of HCC in the West, it is the most common risk factor among certain ethnic groups in the United States. Given the high case fatality of HCC, surveillance efforts have been recommended. Specifically, HCC surveillance has demonstrated a survival benefit in patients with chronic hepatitis B. In this review, we discuss the demographics of patients with HCC in the United States, the evidence promoting surveillance, and recent literature identifying the best surveillance test.

KW - Hepatitis B

KW - Hepatocellular carcinoma

KW - Serum α-fetoprotein

KW - Surveillance

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=79957488406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957488406&partnerID=8YFLogxK

U2 - 10.1007/s11901-011-0098-y

DO - 10.1007/s11901-011-0098-y

M3 - Article

AN - SCOPUS:79957488406

VL - 10

SP - 147

EP - 152

JO - Current Hepatitis Reports

JF - Current Hepatitis Reports

SN - 1540-3416

IS - 2

ER -